Aripiprazole and Telmisartan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Aripiprazole (aripiprazole) and Telmisartan (telmisartan). Common drug interactions include lactic acidosis among females and blindness among males.

The phase IV clinical study analyzes what interactions people have when they take Aripiprazole and Telmisartan. It is created by eHealthMe based on reports of 27 people who take the same drugs from the FDA, and is updated regularly.

What is Aripiprazole?

Aripiprazole has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 39,143 Aripiprazole users. Check the latest studies of Aripiprazole.

What is Telmisartan?

Telmisartan has active ingredients of telmisartan. It is often used in high blood pressure. eHealthMe is studying from 9,163 Telmisartan users. Check the latest studies of Telmisartan.



On Jul, 09, 2026

27 people who take Aripiprazole and Telmisartan together, and have interactions are studied.

Aripiprazole and Telmisartan drug interactions.

What are the common drug interactions of Aripiprazole and Telmisartan, by gender? *:

female:

  1. Lactic acidosis (low ph in body tissues)
  2. Pyrexia (fever)
  3. Altered state of consciousness (altered state of mind)
  4. Blood glucose increased
  5. Decreased appetite
  6. Dehydration (dryness resulting from the removal of water)
  7. Urinary tract infection
  8. Haematocrit decreased
  9. Haemoglobin decreased
  10. Headache (pain in head)

male:

  1. Blindness
  2. Disease progression
  3. Ocular pemphigoid (inflammatory autoimmune disorder characterized by blistering lesions that affect mucous membrane covering of eye)
  4. Visual acuity reduced (reduced clearness of vision)
  5. Angioedema (rapid swelling of the dermis)
  6. Angle closure glaucoma (term used for several ocular diseases that ultimately result in increased intraocular pressure (iop) and decreased visual acuity)
  7. Hepatic steatosis (fatty liver disease)
  8. Lipids increased (excess lipid in body)
  9. Urinary tract infection

What are the common drug interactions of Aripiprazole and Telmisartan, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Angle closure glaucoma (term used for several ocular diseases that ultimately result in increased intraocular pressure (iop) and decreased visual acuity)

40-49:

  1. Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
  2. Lactic acidosis (low ph in body tissues)
  3. Urinary tract infection
  4. Altered state of consciousness (altered state of mind)
  5. Blood glucose increased
  6. Decreased appetite
  7. Dehydration (dryness resulting from the removal of water)
  8. Pyrexia (fever)
  9. Escherichia urinary tract infection (urinary tract infection by escherichia coli)
  10. Angioedema (rapid swelling of the dermis)

50-59:

  1. Anaemia (lack of blood)
  2. Autoimmune disorder (a condition in which the immune system attacks the body's normal substances and tissue)
  3. Bone pain
  4. Cardiac murmur (an heart sound in valve abnormality)
  5. Constipation
  6. Cough
  7. Dyspnoea (difficult or laboured respiration)
  8. Haematocrit decreased
  9. Haemoglobin decreased
  10. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)

60+:

  1. Blindness
  2. Disease progression
  3. Renal tubular necrosis (death of kidney tubules)
  4. Ocular pemphigoid (inflammatory autoimmune disorder characterized by blistering lesions that affect mucous membrane covering of eye)
  5. Visual acuity reduced (reduced clearness of vision)
  6. Acute pulmonary oedema (sudden deposit of fluid in the lung))
  7. Bradycardia (abnormally slow heart action)
  8. Hypercalcaemia (elevated calcium (ca+) level in the blood)
  9. Hyperkalaemia (damage to or disease of the kidney)
  10. Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood)

What are the existing conditions these people have? *

  1. Urticaria (rash of round, red welts on the skin that itch intensely): 9 people, 33.33%
  2. Neurogenic Bladder (the normal function of the bladder is to store and empty urine in a coordinated, controlled fashion): 9 people, 33.33%
  3. Constipation: 9 people, 33.33%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 9 people, 33.33%
  5. Headache (pain in head): 9 people, 33.33%
  6. Type 2 Diabetes: 9 people, 33.33%
  7. Insomnia (sleeplessness): 9 people, 33.33%
  8. Hyperlipidaemia (presence of excess lipids in the blood): 9 people, 33.33%
  9. Ocular Pemphigoid (inflammatory autoimmune disorder characterized by blistering lesions that affect mucous membrane covering of eye): 7 people, 25.93%
  10. Pain: 6 people, 22.22%

* Approximation only. Some reports may have incomplete information.

Do you take Aripiprazole and Telmisartan?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Aripiprazole and Telmisartan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Aripiprazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Telmisartan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Aripiprazole and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Telmisartan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on aripiprazole and telmisartan (the active ingredients of Aripiprazole and Telmisartan, respectively), and Aripiprazole and Telmisartan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: